Liquid biopsy of methylation biomarkers in cell-free DNA
H Luo, W Wei, Z Ye, J Zheng, R Xu - Trends in molecular medicine, 2021 - cell.com
Liquid biopsies, in particular, analysis of cell-free DNA (cfDNA), have emerged as a
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
H Luo, W Wei, Z Ye, J Zheng, R Xu - Trends in Molecular Medicine, 2021 - Elsevier
HighlightsCirculating tumor DNA (ctDNA) is a promising biomarker that exhibits cancer-
specific genetic and epigenetic aberrations, which can be used as a surrogate source of …
specific genetic and epigenetic aberrations, which can be used as a surrogate source of …
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
H Luo, W Wei, Z Ye, J Zheng… - Trends in molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Liquid biopsies, in particular, analysis of cell-free DNA (cfDNA), have emerged as a
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
H Luo, W Wei, Z Ye, J Zheng, R Xu - Trends in Molecular Medicine, 2021 - cell.com
Liquid biopsies, in particular, analysis of cell-free DNA (cfDNA), have emerged as a
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
H Luo, W Wei, Z Ye, J Zheng, RH Xu - Trends in Molecular …, 2021 - europepmc.org
Liquid biopsies, in particular, analysis of cell-free DNA (cfDNA), have emerged as a
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …
promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA …